<i>LPAR1</i> (R163W) mutation promotes cell mobility through activation of Rho pathway.
Jun Wei(Jilin Medical University), Javed Masood Khan(Aligarh Muslim University), Patricia S. Steeg(National Cancer Institute), J. Silvio Gutkind(National Institutes of Health), Laura Hurd, Peter A. Johansson(AstraZeneca (Sweden)), Catherine Tolman, Rajesh Patidar, Xinyu Wen, Adam Cheuk(National Institutes of Health), Young Song(University of British Columbia), Li Chen(Qingdao University), Jean‐Claude Marshall(Pfizer (United States)), Samuel Li(Pfizer (United States)), José Pedro Vaqué Díez, Thomas Badgett, Yanlin Yu(National Institutes of Health)
Cited by 0
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
|Nature Genetics|2011|2k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
Brain metastases
|Nature Reviews Disease Primers|2019|1.1k